CYBERDYNE (JP:7779) has released an update.
CYBERDYNE Inc. has received certification for its new Medical Vital Sensor ‘Cyvis M100’ in Japan, which will soon be covered by public health insurance. This innovative device promises to enhance cardiac monitoring with its ability to record heart activity for up to 10 days, aiding in the early detection and treatment of serious conditions like atrial fibrillation. The company plans to expand the Cyvis series to include additional health metrics, contributing to comprehensive healthcare solutions.
For further insights into JP:7779 stock, check out TipRanks’ Stock Analysis page.